Cell Biotech Co Ltd
KOSDAQ:049960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
KR |
|
Ross Stores Inc
NASDAQ:ROST
|
US |
|
Alta Equipment Group Inc
NYSE:ALTG
|
US |
|
T
|
Temir Corp
OTC:TMRR
|
HK |
|
Holista CollTech Ltd
ASX:HCT
|
AU |
|
Haier Smart Home Co Ltd
SSE:600690
|
CN |
|
First Solar Inc
NASDAQ:FSLR
|
US |
|
E
|
eXoZymes Inc
NASDAQ:EXOZ
|
US |
|
K
|
Kimberly-Clark Corp
F:KMY
|
US |
|
Saipem SpA
MIL:SPM
|
IT |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
G
|
GCCP Resources Ltd
SGX:41T
|
MY |
|
A
|
Alexandria Real Estate Equities, Inc
F:A6W
|
US |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
C
|
CaixaBank SA
SWB:48CA
|
ES |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Doubleview Gold Corp
F:1D4
|
CA |
|
B
|
Bluecom Co Ltd
KOSDAQ:033560
|
KR |
|
Siemens AG
XETRA:SIE
|
DE |
|
B
|
Binh Duong Construction & Civil Engineering JSC
VN:BCE
|
VN |
|
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
KR |
|
B
|
BASF SE
DUS:BAS
|
DE |
|
R
|
Randstad NV
OTC:RANJF
|
NL |
Bankruptcy Probability
Cell Biotech Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cell Biotech Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Cell Biotech Co Ltd
KOSDAQ:049960
|
102.1B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cell Biotech Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cell Biotech Co Ltd has total debt of 74.3m KRW. This includes both short-term (0 KRW) and long-term (74.3m KRW) debt.
You can find a full breakdown on its Balance Sheet.